Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: Oncologic outcomes and morbidity in 1002 patients

European Urology

Volumn 65, Issue 5, 2014, Pages 907-914

  Crouzet, Sebastien ^a,b   Chapelon, Jean Yves ^b   Rouvière, Olivier ^a   Mege Lechevallier, Florence ^a   Colombel, Marc ^a   Tonoli Catez, Hélène ^a   Martin, Xavier ^a   Gelet, Albert ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LABTAU   (France)

Author keywords

Disease free survival; High intensity focused ultrasound ablation; Localized prostate cancer; Survival rate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLADDER NECK STENOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH RISK PATIENT; HUMAN; INCONTINENCE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MORBIDITY; OUTCOMES RESEARCH; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SALVAGE THERAPY; SURVIVAL RATE; VERY ELDERLY;

DISEASE-FREE SURVIVAL; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; LOCALIZED PROSTATE CANCER; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL; URINARY BLADDER NECK OBSTRUCTION; URINARY INCONTINENCE;

EID: 84896390959     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.04.039     Document Type: Article

References (30)

1. J. Riviere, J.C. Bernhard, and G. Robert et al. Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer Eur Urol 58 2010 567 573
2. L. Poissonnier, J.Y. Chapelon, and O. Rouviere et al. Control of prostate cancer by transrectal HIFU in 227 patients Eur Urol 51 2007 381 387
3. A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer, I: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
4. M. Warmuth, T. Johansson, and P. Mad Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer Eur Urol 58 2010 803 815
5. C. Chaussy, and S. Thuroff The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection Curr Urol Rep 4 2003 248 252
6. R. Ganzer, S. Rogenhofer, and B. Walter et al. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer Eur Urol 53 2008 547 553
7. A. Ingelman-Sundberg, and U. Ulmsten Surgical treatment of female urinary stress incontinence Contrib Gynecol Obstet 10 1983 51 69
8. M. Bolla, L. Collette, and L. Blank et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 2002 103 106
9. T. Uchida, S. Shoji, and M. Nakano et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience Int J Urol 16 2009 881 886
10. A. Blana, C.N. Robertson, and S.C. Brown et al. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry Prostate Cancer Prostatic Dis 15 2012 256 259
11. V. Beckendorf, S. Guerif, and E. Le Prise et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial Int J Radiat Oncol Biol Phys 80 2011 1056 1063
12. S. Crouzet, X. Rebillard, and D. Chevallier et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients Eur Urol 58 2010 559 566
13. M.J. Zelefsky, V.E. Reuter, Z. Fuks, P. Scardino, and A. Shippy Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer J Urol 179 2008 1368 1373 discussion 1373
14. A. Zapatero, R. Mínguez, S. Nieto, C. Martín de Vidales, and F. García-Vicente Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us? Eur Urol 55 2009 902 910
15. S.A. Boorjian, R.J. Karnes, and P.L. Crispen et al. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era J Urol 183 2010 1003 1009
16. O. Rouviere, N. Girouin, and L. Glas et al. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI Eur Radiol 20 2010 48 55
17. O. Rouvière, L. Glas, and N. Girouin et al. Transrectal HIFU ablation of prostate cancer: assessment of tissue destruction with contrast-enhanced ultrasound Radiology 259 2011 583 591
18. A. Bill-Axelson, L. Holmberg, and M. Ruutu et al. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
19. A.J. Stephenson, M.W. Kattan, and J.A. Eastham et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era J Clin Oncol 27 2009 4300 4305
20. M.J. Zelefsky, J.A. Eastham, and A.M. Cronin et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 2010 1508 1513
21. M.J. Zelefsky, X. Pei, and J.F. Chou et al. Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes Eur Urol 60 2011 1133 1139
22. J.E. Sylvester, P.D. Grimm, and J. Wong et al. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience Int J Radiat Oncol Biol Phys 81 2011 376 381
23. F. Abdollah, M. Sun, and J. Schmitges et al. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort Eur Urol 60 2011 920 930
24. S. Kim, S. Shen, and D.F. Moore et al. Late gastrointestinal toxicities following radiation therapy for prostate cancer Eur Urol 60 2011 908 916
25. S.A. Shikanov, K.C. Zorn, G.P. Zagaja, and A.L. Shalhav Trifecta outcomes after robotic-assisted laparoscopic prostatectomy Urology 74 2009 619 623
26. B.N. Breyer, C.B. Davis, J.E. Cowan, C.J. Kane, and P.R. Carroll Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy BJU Int 106 2010 1734 1738
27. S.P. Elliott, M.V. Meng, and E.P. Elkin et al. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE J Urol 178 2007 529 534 discussion 534
28. G.J. van der Wielen, W.L. van Putten, and L. Incrocci Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial Int J Radiat Oncol Biol Phys 68 2007 479 484
29. N.N. Stone, and R.G. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342
30. S. Asterling, and D.R. Greene Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer BJU Int 103 2009 788 792